Tomatidine inhibits iNOS and COX-2 through suppression of NF-κB and JNK pathways in LPS-stimulated mouse macrophages  by Chiu, Feng-Lan & Lin, Jen-Kun
FEBS Letters 582 (2008) 2407–2412Tomatidine inhibits iNOS and COX-2 through suppression of NF-jB and
JNK pathways in LPS-stimulated mouse macrophages
Feng-Lan Chiu, Jen-Kun Lin*
Institute of Biochemistry and Molecular Biology, College of Medicine, National Taiwan University, No. 1 Section 1, Jen-ai Road, Taipei 10018, Taiwan
Received 30 March 2008; revised 30 May 2008; accepted 30 May 2008
Available online 9 June 2008
Edited by Beat ImhofAbstract We use the LPS-stimulated macrophage as a model
of inﬂammation to investigate the anti-inﬂammatory eﬀects of
tomatidine and solasodine, whose structures resemble glucocorti-
coids. We found that tomatidine exhibited a more potent anti-
inﬂammatory eﬀect than solasodine. Tomatidine could decrease
inducible nitric oxide synthase and cyclooxygenase-2 expression
through suppression of I-jBa phosphorylation, NF-jB nuclear
translocation and JNK activation, which in turn inhibits c-jun
phosphorylation and Oct-2 expression. Here, we demonstrate
that tomatidine acts as an anti-inﬂammatory agent by blocking
NF-jB and JNK signaling, and may possibly be developed as
a useful agent for the chemoprevention of cancer or inﬂamma-
tory diseases.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Oct-21. Introduction
Inﬂammation is involved in numerous diseases, such as
chronic inﬂammatory disease and the development of cancer
[1–3]. Many stimuli can activate inﬂammatory leukocytes, such
as macrophages, resulting in the induction and synthesis of
proinﬂammatory proteins and enzymes. The release of large
amounts of proinﬂammatory and cytotoxic nitric oxide (NO)
and prostaglandins (PGs) has been associated with many
inﬂammatory conditions, through the activity of their induc-
ible enzymes, inducible nitric oxide synthase (iNOS) and cyclo-
oxygenase-2 (COX-2) [1–4]. The macrophage inﬂammatory
response induced by the bacterial endotoxin lipopolysaccha-
ride (LPS) activates several intracellular signaling pathways
including the Ij-B kinase (IKK)–NF-jB pathway and three
mitogen-activated protein kinase (MAP kinase) pathways:
extracellular signal-regulated kinase (ERK) 1 and 2, c-jun N-
terminal kinase (JNK) and p38 [5]. In addition, octamer
(Oct) factors are another class of transcription factors that
play a central role in the immune system [6]. In a recent study,
it was shown that the transcription factor Oct-2 binds to the
octamer motif in the iNOS promoter [7].
Many plants in the Solanaceae family, such as tomatoes,
potatoes and eggplant, possess steroidal alkaloids based on a*Corresponding author. Fax: +886 2 2391 8944.
E-mail address: jklin@ha.mc.ntu.edu.tw (J.-K. Lin).
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These compounds are essentially nitrogen analogues of steroid
saponins such as diosgenin, which is a precursor of steroidal
hormones and anti-inﬂammatory steroids [8]. Steroidal alka-
loids and their glycosides are known to possess a variety of bio-
logical activities, including antifungal and antibacterial actions
[9,10]. However, understanding of the anti-inﬂammatory eﬀects
of steroidal alkaloids is very limited. The structure of steroidal
alkaloids is similar to that of glucocorticoids. In addition, cor-
ticoids mainly inhibit inﬂammatory responses requiring iNOS-
mediatedNOproduction andCOX-2 expression. Here, we have
investigated whether the steroidal alkaloids tomatidine and sol-
asodine could also inhibit expression of the inﬂammatory en-
zymes iNOS and COX-2 in LPS-stimulated macrophages, and
we have examined the underlying mechanism of action.2. Materials and methods
2.1. Agents
Fig. 1 illustrates the chemical structures of tomatidine, solasodine
and diosgenin, all of which were purchased from Sigma–Aldrich
Chemical Co. (St. Louis, MO, USA). Tomatidine was dissolved in
DMSO, and the concentration was adjusted to 50 mmol/L. Solasodine
and diosgenin were dissolved in 100% ethanol, and the concentration
was adjusted to 25 mmol/L, as stock solutions.
2.2. Cell culture
RAW 264.7 cells, derived from murine macrophages, were obtained
from the American Type Culture Collection (Rockville, MD, USA)
and cultured in DMEM supplemented with 10% endotoxin-free,
heat-inactivated fetal calf serum (Gibco, Grand Island, NY, USA),
penicillin (100 units/mL), and streptomycin (100 lg/mL; Gibco) in a
5% CO2 atmosphere at 37 C in a humidiﬁed incubator. For all assay,
cell was plated at 2 · 105 cells/cm2 in culture dishes or plates. Treat-
ment with vehicle (0.1% DMSO or 0.1% ethanol), test compounds
and/or LPS was carried out under serum-free conditions.
2.3. Nitrite assay
The nitrite concentration in the RAW 264.7 cell culture medium was
measured as an indicator of NO production, according to the Griess
reaction [11]. Brieﬂy, the cells were treated with the test compounds
for 1 h before the addition of LPS, and the cells were further incubated
for 24 h. The isolated supernatants were mixed with an equal volume
of Griess reagent and incubated at room temperature for 10 min;
absorbance of the mixture at 550 nm was determined with a Dynatech
MR-7000 enzyme-linked immunosorbant assay plate reader (Dynatech
Labs, Chantilly, VA).
2.4. PGE2 assay
The medium from cultured RAW 264.7 cells was collected for the
determination of prostaglandin E2 (PGE2) concentrations by en-
zyme-linked immunosorbent assay (ELISA; R&D Systems, Minneap-
olis, MN, USA), according to the manufacturers protocol. Brieﬂy, theblished by Elsevier B.V. All rights reserved.
Fig. 1. The chemical structures of tomatidine, solasodine and
diosgenin.
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of LPS, and the cells were further incubated for 16 h. Cultured medium
was incubated in goat anti-mouse microplate coated with a goat anti-
mouse PGE2 with PGE2-conjugated to horseradish peroxidase (HRP)
with red dye for 2 h at room temperature. The plate was emptied and
rinsed ﬁve times with wash buﬀer contained in the kit. And then,
200 lL of substrate reagent was added to each well and incubated
for 30 min at room temperature. The developed plate was read at
450 nm and the PGE2 concentration of each sample was determined
according to the standard curve.
2.5. Western blot analysis
Details of the procedure for immunoblotting have been described
previously [12]. Immunoreactive protein bands were visualized using
a chemiluminescent substrate and quantitated using the Bio-Rad (Her-
cules, CA, USA) PDQuest Image software and normalized against
bands for either b-actin or a-tubulin (Sigma Chemical Co.). The fol-
lowing antibodies were used: anti-iNOS, anti-NF-jB and anti-Oct-2
(Santa Cruz Biotechnology, CA, USA), anti-COX-2 (BD Transduc-
tion Laboratories, San Jose, CA, USA). Anti-I-jBa and anti-phos-
pho-I-jBa, and anti-MAPKs and anti-phospho-MAPKs antibodies
were purchased from Cell Signaling Technology Inc. (Danvers, MA,
USA).
2.6. Analysis of p65/DNA binding
Cells were serum-starved for 2 h, followed by incubation without
and with the indicated concentration of Td for 1 h and then LPS for
an additional 30 min. After treatment, nuclear extracts were prepared
[13] and DNA binding activity was quantiﬁed using the ELISA-based
Trans-AM NF-jB p65 Kit (Active Motif, Carlsbad, CA, USA),
according to the manufacturers protocol. Brieﬂy, nuclear extracts
(5 lg of protein per well) were incubated in 96-well plates coated with
immobilized oligonucleotide, containing a NF-jB consensus binding
site. NF-jB binding to target oligonucleotides was detected by incuba-
tion of samples with primary antibodies against the p65 subunit pro-
vided with the kit. For quantiﬁcation of activity, optical densities
were measured at 450 nm with a microplate reader.2.7. Statistics
Statistical analysis was based on the standard error of the mean, and
P values determined using an independent sample, two-tailed Students
t-test assuming equal variances.3. Results
3.1. Eﬀect of tomatidine, solasodine and diosgenin on nitric oxide
production and iNOS protein expression in LPS-stimulated
RAW 264.7 macrophage cells
To investigate the eﬀect of tomatidine, solasodine and dios-
genin on NO production, we measured the accumulation of ni-
trite, the stable metabolite of NO, in culture media using
Griess reagent. We examined the inhibition of NO production
in treatment of RAW 264.7 cells with test compounds either
prior to stimulation with LPS (pretreatment) or with LPS at
the same time (co-treatment). The preliminary results indicated
that the pretreatment protocol was more eﬀective on inhibiting
NO production. Therefore, in this study we used the pretreat-
ment of the cells with test compounds and then challenged
with LPS in all experiments. As shown in Fig. 2A, LPS evoked
an eight-fold increase of nitrite production compared with the
naı¨ve control, and this induction was inhibited in a dose-
dependent manner by treatment with the test compounds. In
similar treatments, tomatidine, solasodine and diosgenin
(40 lmol/L) showed 66%, 22% and 41% inhibition of nitrite
production, respectively. The iNOS protein was barely detect-
able in unstimulated cells but markedly increased after LPS
treatment, and tomatidine caused dose-dependent inhibition
of LPS-induced iNOS expression (Fig. 2B). These results indi-
cated that tomatidine have a more potent inhibitory eﬀect than
diosgenin and solasodine.3.2. Eﬀect of tomatidine on PGE2 production and COX-2 protein
expression in LPS-stimulated RAW 264.7 cells
To characterize further the role of tomatidine in anti-inﬂam-
matory events, we studied the expression of another important
proinﬂammatory enzyme, COX-2. PGE2 is a major product of
the metabolism of arachidonic acid via the COX pathway in
macrophages exposed to stimuli that elicit immediate re-
sponses [14]. As shown in Fig. 3A and B, COX-2 and PGE2
were barely detectable in unstimulated cells, but markedly in-
creased after LPS treatment. Tomatidine suppressed the
COX-2 protein level in a dose-dependent manner (Fig. 3A),
and PGE2 production was decreased by tomatidine (Fig.
3B). These results indicated that tomatidine could modulate
inﬂammatory eﬀects through inhibition of the COX pathway.
3.3. Eﬀect of tomatidine on LPS-induced degradation of I-jBa
and activation of NF-jB
To clarify the mechanism of action of tomatidine in the inhi-
bition of the LPS-induced expression of iNOS and COX-2, the
eﬀects of tomatidine on LPS-induced degradation of I-jBa
and activation of NF-jB were examined. Treatment of cells
with tomatidine for 1 h before the addition of LPS inhibited
the LPS-induced NF-jB nuclear translocation (Fig. 4A). Be-
cause p65 is the major component of NF-jB in LPS-stimulated
macrophages, we determined the eﬀect of tomatidine on p65
DNA-binding activity. In the presence of tomatidine at 10–
40 lmol/L, the binding activity of NF-jB was suppressed in
a dose-dependent manner (Fig. 4B).
Fig. 2. Eﬀects of tomatidine, solasodine and diosgenin on LPS-
induced nitrite production and iNOS expression in RAW 264.7 cells.
(A) Inhibition of LPS-induced NO production by tomatidine (Td),
solasodine (Sd) and diosgenin (Dg) in RAW 264.7 cells. The cells were
treated with the indicated concentrations of the test compounds for 1 h
before the addition of 100 ng/mL LPS, and the cells were further
incubated for 24 h. The concentration of nitrite in the culture medium
was monitored, as described in Section 2. Each bar represents the
means ± S.D. from four separate experiments. *P < 0.05 compared
with LPS alone. (B) Inhibition of LPS-induced iNOS expression by the
test compounds tomatidine (Td), solasodine (Sd) and diosgenin (Dg).
The cells were treated with the indicated concentrations of compounds
for 1 h before the addition of 100 ng/mL LPS, and the cells were
further incubated for 16 h. The levels of iNOS protein were monitored,
as described in Section 2. This experiment was repeated four times,
with similar observations in each experiment.
Fig. 3. Eﬀects of tomatidine on LPS-induced PGE2 production and
COX-2 expression in RAW 264.7 cells. The cells were treated with the
indicated concentrations of tomatidine (Td) for 1 h before the addition
of 100 ng/mL LPS, and the cells were further incubated for 16 h. (A)
Inhibition of LPS-induced COX-2 expression by tomatidine. The levels
of COX-2 protein were monitored, as described in Section 2. (B)
Inhibition of LPS-induced PGE2 production by tomatidine in RAW
264.7 macrophages. The concentrations of PGE2 in culture medium
were monitored, as described in Section 2. Each bar represents the
means ± S.D. from three separate experiments. *P < 0.05 compared
with LPS alone. This experiment was repeated four times with similar
observations in each experiment.
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phorylation and degradation of I-jBa [15]. To determine
whether the inhibition of nuclear translocation of NF-jB by
tomatidine is because of an eﬀect on I-jBa degradation, the
cytoplasmic levels of I-jBa were determined. Incubation of
RAW 264.7 cells with LPS for 30 min could induce I-jBa
phosphorylation and degradation; and this induction was
inhibited by tomatidine in a dose-dependent manner (Fig.
4C). These ﬁndings suggest that tomatidine suppresses the ac-
tion of NF-jB at least partly through the inhibition of I-jBa
degradation.
3.4. Eﬀect of tomatidine on LPS-induced phosphorylation of
JNK and c-jun
As MAP kinases have been shown to be required for iNOS
induction mediated by LPS in RAW 264.7 macrophages, we
investigated the eﬀect of tomatidine on the activation of
MAP kinases in LPS-stimulated RAW 264.7 cells. After incu-bation with LPS, the phosphorylation of c-jun was signiﬁcantly
increased, and this activation was blocked by tomatidine
(Fig. 5A and B).
To further determine if inhibition of MAP kinases contrib-
utes to the inhibitory action of tomatidine, cells were pre-
treated with the MEK1/2, p38 and JNK inhibitors—
PD98059, SB203580 and SP600125, respectively—before the
addition of LPS. The LPS-induced increases in iNOS and
COX-2 levels were unaﬀected by PD98059 and SB203580 (data
not shown) but were inhibited by the JNK inhibitor SP600125
(Fig. 5C). Based on this information, it seems that JNK signal-
ing is of primary importance in controlling iNOS and COX-2
expression.
3.5. Eﬀect of tomatidine on LPS-induced Oct-2 expression
The Oct-2 transcription factor had been shown to bind to
the octamer motif in the iNOS promoter [7,16], and Oct-2 is
required for iNOS activation by LPS [17]. To determine
whether tomatidine treatment decreases the level of LPS-in-
duced Oct-2 expression, RAW 264.7 cells were exposed to
LPS with and without tomatidine, and examined using Wes-
tern immunoblot analysis. Incubation of RAW 264.7 cells in
the presence of LPS could induce expression of Oct-2 and this
induction was inhibited by tomatidine in a concentration-
dependent manner (Fig. 6A). To examine further the signaling
cascade triggering the increase in Oct-2 expression by LPS,
speciﬁc pharmacological antagonists were used. The LPS-in-
duced increase in Oct-2 levels was unaﬀected by PD98059
and SB203580 (data not shown) but was blocked by
SP600125 (Fig. 6B). These ﬁndings indicate that inhibition of
LPS-induced iNOS expression by tomatidine may proceed
through down-regulation of Oct-2 by the JNK signaling cas-
cade.
Fig. 4. Eﬀects of tomatidine on LPS-induced NF-jB activation and I-
jBa degradation and phosphorylation in RAW 264.7 cells. The cells
were treated with the indicated concentrations of tomatidine (Td) for
1 h before the addition of 100 ng/ml LPS, and the cells were further
incubated for 30 min. After the isolation of nuclear and cytoplasm
extracts, NF-jB p65 translocation (A) was measured by Western blot,
and NF-jB p65 binding activity (B) was determined, as described in
Section 2. Each bar represents the means ± S.D. from three separate
experiments. *P < 0.05 compared with LPS alone; the proliferating cell
nuclear antigen (PCNA) and a-tubulin as the nuclear and cytosol
fractions marker, respectively. (C) Inhibition of LPS-induced I-jBa
phosphorylation and degradation by tomatidine. RAW 264.7 cells
were treated with the indicated concentrations of tomatidine (Td) for
1 h before the addition of 100 ng/mL LPS, and the cells were further
incubated for 30 min. Western blot analysis was carried out, as
described in Section 2. These experiments were repeated four times
with similar observations in each experiment.
Fig. 5. Eﬀects of tomatidine on LPS-induced phosphorylation of
MAPKs in RAW 264.7 cells. The cells were stimulated with 100 ng/mL
LPS alone or LPS plus tomatidine (Td; 10, 20 and 40 lmol/L) for
30 min, and whole-cell lysates were analyzed by immunoblot analysis
using various antibodies against activated MAPKs (A) and phospho-c-
jun (B). (C) Cells were pretreated with tomatidine (Td; 40 lmol/L) and
SP600125 (SP; 5, 10 or 50 lmol/L) for 1 h before LPS (100 ng/mL)
treatment for 16 h. Whole-cell lysates were analyzed by immunoblot
analysis using various antibodies against iNOS and COX-2. The
results presented are representative of three independent experiments.
Fig. 6. Eﬀect of tomatidine on LPS-induced Oct-2 expression in RAW
264.7 cells. (A) RAW 264.7 cells were pretreated with tomatidine (Td;
10, 20 or 40 lmol/L) for 1 h before LPS (100 ng/mL) treatment for
12 h. (B) Cells were pretreated with tomatidine (Td; 40 lmol/L) and
SP600125 (SP; 5, 10 and 50 lmol/L) for 1 h, then LPS (100 ng/mL) was
added for 16 h. Whole-cell lysates were analyzed by immunoblot
analysis using various antibodies against Oct-2. These experiments
were repeated three times with similar observations in each experiment.
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Tomatidine is the aglycone of tomatine, which is a major to-
mato glycoalkaloid. Tomatidine has been associated with a
variety of eﬀects on human health, including lowering choles-
terol, enhancing immune responses when used as a cancer che-
motherapy agent, and protecting against pathogenic fungi and
other microorganisms [18]. Tomatidine may beneﬁt cancer
chemotherapy by inhibiting multidrug resistance in human
cancer cells [19] and by inhibiting the growth of colon and liver
cancer cells [20]. Tomatidine was developed into a pregnane
derivative possessing neuritogenic and NGF-enhancing activi-
ties [21]. In addition, tomatidine suppresses the oxidative burst
and is able to suppress induced plant defense responses [22,23].
However, the eﬀects of tomatidine on inﬂammatory processes
are still unclear. Our present results provide, for the ﬁrst time,
evidence for the anti-inﬂammatory eﬀects of tomatidine.
Fig. 7. Possible anti-inﬂammatory mechanisms of tomatidine (Td).
LPS-induced activation of macrophages is mainly mediated through
TLR 4 and results in the production of proinﬂammatory mediators
including iNOS and COX-2. The promoter regions of proinﬂamma-
tory mediators contain several binding site for transcriptional factors,
such as jB, AP-1, and Oct. The anti-inﬂammatory eﬀects of tomatidine
are due to repression of NF-jB, c-jun, and Oct-2 acting on diﬀerent
regions of the genes promoter through NF-jB and JNK pathways.
TLR, Toll-like receptor; IKK, inhibitor-jB Kinase; I-jB, inhibitor-jB;
MEKK, mitogen-activated protein kinase kinase kinase; MKK,
mitogen-activated protein kinase kinase; JNK, c-jun N-terminal
kinase; NF-jB, nuclear factor-jB; AP-1, activating protein-1; Oct,
octamer.
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solasodine shows that the major diﬀerence between them is
that tomatidine lacks the double bond in the 5,6 position of
the B-ring. We found that tomatidine was a more potent
anti-inﬂammatory than solasodine. In other words, the ab-
sence of a 5,6 double bond in the B-ring of tomatidine results
in a much stronger anti-inﬂammatory eﬀect compared with the
otherwise structurally similar solasodine (which contains such
a double bond). In addition, the results of our cell viability as-
say indicated that tomatidine is much less toxic than solaso-
dine and diosgenin; with similar concentration treatment
(40 lmol/L) showed 5.5%, 13.5%, and 26.8% growth inhibition
of tomatidine, solasodine, and diosgenin, respectively (data
not shown). Recent studies also indicated that tomatidine is
a much less toxic molecule in both pregnant and nonpregnant
mice when compared with the structurally similar solasodine
[24], and that it does not aﬀect the body and liver weights of
mice [25]. The other diﬀerence between them is that the 25-
methyl group of tomatidine in the nitrogenous F-ring is epi-
meric. Therefore, the relationships between chemical structure
and the anti-inﬂammatory characteristics of tomatidine need
to further investigated. These results show that tomatidine
has the best anti-inﬂammatory eﬀect and least toxicity of the
pair.
The NOS and COX systems are often present together, share
a number of similarities, and play fundamental roles in similar
pathophysiological conditions, such as inﬂammation [26] and
cancer [27]. The transcription factor NF-jB is implicated in
the regulation of many genes that code for mediators of the im-
mune, acute-phase and inﬂammatory responses, e.g. iNOS and
COX-2 [28,29]. The p50/p65 heterodimer is the most common
dimer found in the NF-jB signaling pathway [30]. Activation
of the NF-jB signaling cascade results in the complete degra-
dation of I-jB via phosphorylation and ubiquitination. In our
study, tomatidine inhibited the phosphorylation of I-jB,
blocked the I-jB production, and furthermore suppressed
p65 NF-jB translocation to the nucleus and modulated bind-
ing activity. The role of the MAP kinases in the regulation of
iNOS and COX-2 expression has been investigated intensively.
In this study, we found that incubation of RAW 264.7 cells
with LPS brings about activation of MAP kinases, and that
treatment with tomatidine inhibits LPS-induced phosphoryla-
tion of JNK but not p38 MAPK and ERK. These results sug-
gest that NF-jB and JNK pathways could modulated the
suppression of LPS-induced iNOS and COX-2 expression by
tomatidine (Fig. 7).
The octamer transcription factors are member of the Pit-
Oct-Unc domain family, exerting their eﬀects through binding
to sequences related to the octamer motif (ATGCAAAT) [6].
Oct-1 and Oct-2 are the two most prominent octamer factors.
Oct-1 was identiﬁed as a ubiquitous protein, whereas Oct-2
expression is restricted largely to B lymphocytes [31], but is
also present in macrophages [17,32]. Recent studies have indi-
cated that Oct-2 binds to the octamer motif in the iNOS pro-
moter [7] and is required for iNOS activation by LPS [33].
Our results are consistent with previous studies, and we con-
ﬁrm that Oct-2 is required for iNOS activation by LPS.
Furthermore, we demonstrated that LPS-induced Oct-2
expression was abolished by blocking the MAP kinase path-
way with the JNK inhibitor SP600125 (Fig. 6B), but no eﬀect
was seen with PD980559 and SB203580 (data not shown).
Here, for the ﬁrst time, we demonstrated that JNK pathwaycould be modulated the LPS-induced Oct-2 expression. These
results suggest that tomatidines suppression of LPS-induced
Oct-2 expression through the JNK pathway in turn modu-
lates iNOS expression. Besides, this study indicates that
NF-jB is required for transcriptional activation of the Oct-
2 gene in transformed pre-B lymphocytes [34]. Therefore,
more studies are needed to determine whether tomatidine
inhibits inﬂammatory-mediator expression only through the
MAPK and NF-jB pathways, or by cross-interactive regula-
tion.
LPS-induced activation of macrophages is mainly mediated
through the transmembrane signaling receptor toll-like recep-
tor (TLR) 4 [35]. LPS stimulation of macrophages activates
several intracellular signaling pathways that include the
IKK–NF-jB pathway and three mitogen-activated protein ki-
nase (MAPK) pathways: ERKs 1 and 2, JNK and p38. These
signaling pathways in turn activate a variety of transcription
factors that include NF-jB (p50/p65) [5,36] and activator pro-
tein-1, AP-1 (c-Fos/c-Jun) [37], as well as Octamer (Oct-2)
[7,16], which coordinate the induction of many genes encoding
inﬂammatory mediators. In conclusion, these experiments
demonstrate that tomatidine inhibits LPS-induced expression
of the iNOS and COX-2 genes through suppressing the phos-
phorylation of I-jBa and the activation of NF-jB, and by
inhibiting the JNK pathway, which in turns inhibits c-jun
phosphorylation and Oct-2 expression in RAW 264.7
cells (Fig. 7). Tomatidine shows great potential as an
anti-inﬂammatory agent and may be used in the future as a no-
vel agent for the chemoprevention of cancer or inﬂammatory
diseases.
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